Anthony Dickenson

Anthony Dickenson, FMedSci is Professor of Neuropharmacology[1] at University College, London.

Professor

Anthony Dickenson
Anthony Dickenson at IASP 2010.
Born
Anthony Henry Dickenson

England,
United Kingdom
NationalityBritish
Alma materUniversity of Reading
AwardsFMedSci
Scientific career
FieldsNeuropharmacology
InstitutionsUniversity College London
National Institute for Medical Research
Doctoral advisorJean-Marie Besson

Education

Tony Dickenson received his PhD at the National Institute for Medical Research, London, and has held Fellowships and posts in Paris, California and Sweden.

Career

Tony Dickenson was appointed to the Department of Pharmacology at University College in 1983. He conducted research into the mechanisms of pain and how pain can be controlled in both normal and patho-physiological conditions and how to translate basic science to the patient.

Dickenson has supervised more than 20 completed PhD students as well as contributing to undergraduate science and medical teaching. He is a founding and continuing member of the London Pain Consortium, a Wellcome Trust Integrated Physiology Initiative, which funds a group of scientists in London and Oxford studying pain mechanisms and educating young scientists in this field.[2]

He has authored more than 330 refereed publications[3] including Science and Nature, edited three books and written many chapters. He has also been quoted in the media and in magazine articles as an expert on pain remediation.

Research

At UCL, the focus of his group’s research has been based on understanding the transmission and control of pain, how neuronal systems alter in pathophysiological states and how novel and licensed drugs produce their effects with the aim of translating the basic research into clinical applications.

Early studies described the neuronal basis of Diffuse Noxious Inhibitory controls (DNIC). Tony’s group was also the first to show the NMDA receptor mediation of wind-up and its role in persistent pain. Continuing work on central hyperexcitability has been seminal in understanding of pain in animals and humans.

Studies include collaborations with Prof Frank Porreca of the Department of Pharmacology at the University of Arizona, investigating opioid pathways; collaborations with Prof John Wood of the Molecular Nociception Group, examining tissue specific deletion of targets and studies with Prof Annette Dolphin involving the role of voltage-dependent Ca2+ channels in pathological states.

gollark: As with basically all of my personal tools, this is *not* user-friendly for those not on Linux and/or acquainted with the terminal.
gollark: There are loads online.
gollark: There are other automatic zalgonators, but this one is mine, and CLI-based.
gollark: I͖̦ͅ ̡͚̀c̅́͑a̺͙͋n̅̏̀ ͔͉̫r̘̪͞u̖̗̟n͇͇̈ ͔̗ͯi̓ͯͅt͇͑͛ ̼̀̕m̖͈̈u̼̫ͪl̲͋̿t̜ͪ̆i̷̤͋p̴̜̟l̶̈́̉e͂̐͐ ̧̛ͭt̄̄̆ì͟͡m̹̅͢ȅ̺̺s͊ͬ̈,̞͓̂ ̴͊ͮt͇ͩ̑o̗͙̫ỏ̷̢.͈͔͝
gollark: I wrote a simple program which takes text and outputs it with diacritics added.

References
  1. "UCL". Profile.
  2. "The London Pain Consortium - Welcome to London Pain Consortium".
  3. pubmeddev. "dickenson ah - PubMed - NCBI". nih.gov.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.